File(s) not publicly available
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
journal contributionposted on 2023-06-07, 21:37 authored by Eva Martinez-Garcia, Relja Popovic, Dong-Joon Min, Steve M M Sweet, Paul M Thomas, Leonid Zamdborg, Aaron Heffner, Christine Will, Laurence Lamy, Louis M Staudt, David L Levens, Neil L Kelleher, Jonathan D Licht
The multiple myeloma SET domain (MMSET) protein is overexpressed in multiple myeloma (MM) patients with the translocation t(4;14). Although studies have shown the involvement of MMSET/Wolf-Hirschhorn syndrome candidate 1 in development, its mode of action in the pathogenesis of MM is largely unknown. We found that MMSET is a major regulator of chromatin structure and transcription in t(4;14) MM cells. High levels of MMSET correlate with an increase in lysine 36 methylation of histone H3 and a decrease in lysine 27 methylation across the genome, leading to a more open structural state of the chromatin. Loss of MMSET expression alters adhesion properties, suppresses growth, and induces apoptosis in MM cells. Consequently, genes affected by high levels of MMSET are implicated in the p53 pathway, cell cycle regulation, and integrin signaling. Regulation of many of these genes required functional histone methyl-transferase activity of MMSET. These results implicate MMSET as a major epigenetic regulator in t(4;14)+ MM.
PublisherAmerican Society of Hematology
Department affiliated with
- Sussex Centre for Genome Damage Stability Publications
Full text available